Large-insert genome analysis (LIGAN) is a broadly applicable, high-throughput technology designed to characterize genome-scale structural variation. Fosmid paired-end sequences and DNA fingerprints from a query genome are compared to a reference sequence using the Genomic Variation Analysis (GenVal) suite of software tools to pinpoint locations of insertions, deletions, and rearrangements. Fosmids spanning regions that contain new structural variants can then be sequenced. Clonal pairs of Pseudomonas aeruginosa isolates from four cystic fibrosis patients were used to validate the LIGAN technology. Approximately 1.5 Mb of inserted sequences were identified, including 743 kb containing 615 ORFs that are absent from published P. aeruginosa genomes. Six rearrangement breakpoints and 220 kb of deleted sequences were also identified. Our study expands the "genome universe" of P. aeruginosa and validates a technology that complements emerging, short-read sequencing methods that are better suited to characterizing single-nucleotide polymorphisms than structural variation.
Genome structural variation, including large (N1 kb) insertions, deletions, inversions, and translocations, contributes to genetic diversity and disease susceptibility [1] [2] [3] . Structural variants have been identified using several approaches [1, 2] ; however, except for direct sequencing methods, these techniques have at least one of the following limitations: (1) they do not provide a genomic context for variable regions and (2) they do not readily identify regions that are not represented in the sequenced reference genome(s). The largeinsert genome analysis (LIGAN) technology reported here has the distinct advantage of locating novel genomic sequences and rearrangements in any genome of interest compared to sequenced reference genomes. The conceptual framework for the technology is illustrated in Fig. 1 . It is based on a fosmid cloning strategy that limits inserts from approximately 32 to 48 kb in length; however, the technology can utilize any double-stranded, clone-based data source.
Pseudomonas aeruginosa is a gram-negative bacterium that accounts for 10 to 20% of nosocomial infections, the most serious of which include endocarditis, meningitis, pneumonia, and septicemia; and it is particularly infectious in patients with burn wounds, acute leukemia, organ transplants, and intravenous-drug addiction [4] . This ubiquitous environmental bacterium also causes chronic pulmonary infections in patients with cystic fibrosis (CF). The ability of P. aeruginosa to thrive in varied environmental habitats and its resistance to antibiotics and disinfectants have led to its emergence as a major opportunistic pathogen. The versatility and vitality of P. aeruginosa is due in part to a genome that contains an extensive collection of regulatory genes and multiple resistance mechanisms [5] . Characterization of P. aeruginosa genome diversity has contributed to the understanding of mechanisms of pathogenesis and factors that influence therapeutic outcomes [6, 7] . Previous studies of clinical and environmental strains suggest that the Pseudomonas genome consists of a conserved backbone with islands of chromosomal genes that are variably present across strains [8] ; thus, P. aeruginosa has a population-based "supragenome" that is multiple times the size of an individual strain's genome [9] .
Fosmid libraries were generated for clonal pairs of P. aeruginosa isolates from four cystic fibrosis patients (Table 1) . Fosmid end sequences and fingerprints for approximately 1000 randomly picked clones from each library were analyzed using Genomic Variation Analysis (GenVal) software to identify structural variants relative to the P. aeruginosa PAO1 reference genome [5] . Deletions relative to PAO1 were reported earlier in five of the strains, PACS171b, PACS88, PACS416, PACS5296, and PACS181, in the microarray study by Ernst et al. [10] . In the present study, we confirmed all of the deletions detected by microarray analysis and, in addition, identified novel insertions and genome rearrangements not detected by this earlier study [10] . Thus, we used clinical strains of P. aeruginosa as a proof-of-principal model system to establish LIGAN technology, and in the process, we uncovered a greater diversity of structural variants in P. aeruginosa clinical strain genomes than has been previously described.
Results

Principal of method
GenVal software (http://depts.washington.edu/uwgcmed/software. html) uses fosmid paired-end sequences and restriction-enzyme DNA fingerprints from multiple, complete digests (MCD) [11] to determine all positions in the reference sequence where each of the clones might reside; the accumulation of all such positions constitutes a tiling ( Fig. 2a ). The tiling of fosmids from a query genome against a reference sequence is used as the basis for structural variation analysis. GenVal requires: (1) a reference genome sequence, (2) a query-strain-specific file containing an aggregation of fosmid paired-end sequences and MCD-fingerprint data for the query genome, and (3) the fosmid vector sequence. The reference sequence is used to anchor the fosmid pairedend sequences and to create virtual sequence-derived fragments (SDFs), which are compared to MCD gel fragments (GFs) of the query fosmids ( Fig. 2b ). The process proceeds in the following manner. First, paired-end sequences are aligned to the reference sequence using the Smith-Waterman algorithm [12] to establish clone boundaries along the reference genome. If both end sequences for a clone align in the correct orientation and within the length bounds of a fosmid, a full position is formed; otherwise, one or more half positions may be formed. Half positions occur for a number of reasons, including duplicated or repeat sequences in the reference genome, large indels, rearrangements, or absence of end-sequence data. Second, the software compares the MCD-derived GFs to corresponding virtual SDFs within the bounds of the anchors or within the estimated extent of a half position as described Schematic of LIGAN technology. One reference genome (Ref) and three query genomes (Q1, Q2, and Q3) are shown. Fosmid libraries are constructed from each query genome, and paired-end sequences and DNA fingerprints from multiple, complete digests (MCD) are generated from randomly picked clones providing 6-8× physical coverage of the query genome. Clones are tiled against the reference sequence; fosmid paired-end sequences (green and orange arrows) anchor clone inserts and MCD fingerprints are compared to virtual reference-sequence-derived fragments. Deletions in the query genome are indicated when the apparent length of the anchored clone, based on paired-end sequences, is greater than the physical clone insert length, based on MCD fingerprints. Insertions in the query genome are indicated when the length of the anchored clone is less than the physical clone insert length. Clones spanning inversion breakpoints have paired-end sequences that do not point toward each other and are thus inconsistent with a normal fosmid tiling, with or without any of the insert size discrepancies described for deletions and insertions. below, to obtain the best matching possible using appropriate latitude for measurement errors (supplementary material). User-defined thresholds in the software determine both the creation of end sequence anchors and the pairing of GFs and SDFs.
The GFs resulting from restriction digests of fosmids include: (1) vector fragments, (2) junction fragments composed of part insert and part vector DNA, and (3) insert fragments derived from the fosmid-insert DNA. During the matching process, all GFs resulting from digestion are accounted for, including vector fragments, junction fragments, and insert fragments. If, for all restriction digests, the oneto-one correspondence includes all GFs and all SDFs, the position is considered perfect; otherwise, it contains defects of one or more forms. A defect is present if there is: (1) an unpaired SDF, known as map residue; (2) an unpaired GF, known as fingerprint residue; (3) a vector fragment that cannot be identified, known as vector-fragment residue; or (4) a junction fragment that cannot be identified, known as junction-fragment residue. Such defects are properties by which positions are categorized and filtered in GenVal. For half positions, the extent of the unanchored clone insert end is determined by a binary search approach; that is, the software searches for the end, along the virtual restriction map of the reference sequence, that minimizes the number of defects.
GenVal can produce three different types of clone positions: combined, end sequence, and fingerprint. A combined position is created when there is significant matching of the fosmid GFs to the virtual SDFs within the bounds of a full position that is defined by the pairedend sequences or within the estimated extent of a half position. Combined positions provide the most precise information for structural variation analysis, because the end sequence anchoring delimits a given region of interest and the fine-grained fingerprint matching pinpoints the location and size of the variation in that region. In contrast, an end sequence position is created when either (1) fingerprint data are unavailable for a clone or (2) significant mismatching occurs between the GFs and the SDFs within the bounds of a full position or within the estimated extent of a half position. A fingerprint position is created when (1) no combined position can be created, because either the end sequences are unavailable or they do not match the reference sequence, and (2) there is significant matching of GFs and SDFs along the reference genome. A two-pronged binary search is applied simultaneously at both ends of the fosmid to delimit fingerprint positions.
GenVal automatically compiles all potential locations of structural variation into a "regions of interest" table (not shown) for review and further analysis. The software identifies structural variants less than an average fosmid length using the average insert length difference ( Fig. 2a ), which is the difference between estimates of the clone insert lengths from the end-sequence anchors and the average-insert-size estimates from MCD fingerprints. At insertion sites where the query strain contains more DNA than the reference, the clone lengths based on the end-sequence anchors are shorter than those based on the MCD fingerprints ( Fig. 1 ). In contrast, at deletion sites where the query strain contains less DNA than the reference, the clone lengths based on the end-sequence anchors are longer than those based on the MCD fingerprints ( Fig. 1 ). GenVal identifies structural variants greater than an average fosmid length using the orientation of clusters of clones that tile with half positions ( Fig. 2a ). For insertions larger than typical fosmid length, the clones spanning the insertion boundary have only one end sequence that aligns with the reference sequence, the other end being specific to the query strain. A unique cluster of clones with half positions, defined as "edge clones," occurs on each side of large insertions ( Fig. 2a ). Deletions larger than a typical fosmid length are bracketed by two nonoverlapping clusters of half positions, each cluster containing the same set of clones (not shown). Similar to large deletions, breakpoints delimiting inversions and other rearrangements larger than typical fosmid length are flanked by nonoverlapping clusters of half positions; however, at breakpoints each cluster contains a different set of clones ( Fig. 1 ). Based on the breakpoints, GenVal decomposes the reference sequence into segments and reassembles these segments in the order and orientation that they occur in a query strain to provide an overview of the structure of the query strain's genome (not shown).
The software's de novo contig building utility, which is based on the classical algorithmic contig-building approach of sorting probabilities of overlap [13, 14] , constructs contigs using MCD fingerprints from clones that did not tile against the reference sequence and clones that span large insertion boundaries (supplementary material). GenVal uses a surrogate metric for the probability of overlap, the Composite Mutual Overlap Statistic (CMOS). The CMOS is computed over all restriction enzyme domains and involves the ratio of the number of restriction fragments that are apparently in common between two clones to the number of fragments that are present in each clone. A CMOS threshold that implies roughly a 50% clone overlap is most effective for such contig building. Contig building is valuable for placing large insertions in the context of the query genome and for identifying a minimum set of clones to sequence. An approach related to LIGAN, called the pair-end sequencing method, has been used in Francisella tularensis [15] ; however, it relied on long-range PCR of λ phage clone inserts to measure the physical distance between paired-end reads and did not provide fine-grained details about structural variants or an opportunity for de novo contig building, which are available with LIGAN technology.
Structural variation analysis of P. aeruginosa clinical strains
For the present study, inputs to GenVal software were: (1) the P. aeruginosa PAO1 reference genome sequence [5] and (2) for each P. aeruginosa clinical strain (PACS) a file containing the pCC1Fos vector sequence and an aggregation of fosmid paired-end sequences and MCDfingerprint data. Regions exhibiting structural variation, and representative clones spanning them, were compiled for each query genome in the software's region of interest table. Regions of interest were validated by manual review of the tiling of each query genome. A region was chosen for more detailed analysis when: (1) it was spanned by a minimum of three clones-the third clone provided a tie-breaker in case the other two produced mixed signals-and (2) the average insert length difference was 3 kb or greater, which is 2.5 standard deviations in the average insert length difference for the "self" tiling of PAO1 fosmids against the PAO1 genome. These thresholds resulted in no false positives and one false negative in our control experiments (discussed below).
A set of clones spanning each unique rearrangement breakpoint was sequenced from a single isolate. Insertions in each isolate were further investigated in the following manner. First, representative clones spanning insertions less than a fosmid length, edge clones flanking and extending into insertions greater than a fosmid length, and the subset of clones that did not tile against PAO1 were tiled against the PA14 genome [16] and the combined assembly of the sequenced PACS416 and PACS5296 genomes (Table 1) , called PACS2 (GenBank Accession No. NZ_AAQW00000000, supplementary material). If a fosmid matched a region of the PA14 or PACS2 genome, the clone was considered to contain previously characterized DNA and was annotated based on the matching reference genome. Clones spanning insertions less than a fosmid length without a match were sequenced to identify the strainspecific DNA.
All clones that did not tile against the three reference genomes and edge clones flanking novel insertions were further analyzed by de novo contig building. Clones from contigs composed of paired-edge clones, with or without a minimal tiling path of internal clones, were sequenced for further investigation.
Control experiments using isolates PACS416 and PACS5296 from CF Patient 9
Four pairs of early-late PACS from CF patients were analyzed in the current study (Table 1) . Paired-end sequences and fingerprints from NcoI, SmaI, and XhoI restriction digests were attempted for 960 independent fosmid clones per isolate. The PACS2 assembly provided an experimental control for LIGAN studies of the PACS416 and PACS5296 genomes from Patient 9. Based on the 913 PACS416 and 915 PACS5296 clones that tiled against PAO1, GenVal predicted 15 insertions, 11 deletions, and 2 rearrangement breakpoints for PACS416 and predicted the same events for PACS5296 with two exceptions: (1) one additional rearrangement breakpoint and (2) a 188-kb deletion spanning 139 genes in PAO1 (Supplementary Table 1 ). Of the 47 PACS416 clones that did not tile against PAO1, 10 had incomplete or poor quality data, and the remaining 37 tiled against PACS2 in regions that are either entirely absent from or highly discrepant in structure in the PAO1 genome [5] . Of the 45 PACS5296 clones that did not tile against PAO1, 2 had incomplete or poor quality data and the remaining 43 clones tiled against PACS2 in unique or hypervariable regions relative to PAO1.
A previous PAO1-based microarray study [10] and direct comparison of the PACS2 and PAO1 sequences confirmed all of the GenValpredicted regions of interest, except for a single structural variant N3 kb in size in PACS416 at the pyoverdine locus (2.65 Mb in PAO1). This was not initially included as a region of interest because the fosmid coverage was below the three-clone minimum threshold. Despite low coverage, clones tiled at this site signaled a deletion.
In total, 6% of the PACS416 and PACS5296 genomes is not represented in the PAO1 genome. One percent of the PAO1 genome is missing from the PACS416 genome, and 3% is missing from the PACS5296 genome. Thus, structural variants accounted for up to 9% of the genomic variation in these Pseudomonas isolates compared to the PAO1 reference sequence.
Structural variation in early-late paired clinical isolates from CF Patients 4, 102, and 206
A total of 66 insertions were identified in the paired isolates from Patients 4, 102, and 206 ( Table 2 ). With only two exceptions in Patient 4 (discussed below), there was concordance of insertions in the early and late isolates in each patient. Seventeen of the 66 insertions were shared with the isolates from Patient 9 described above or P. aeruginosa strain PA14 and were thus annotated accordingly without further analysis. Nine of these 17 shared insertions contained previously characterized genomic islands: (1) the clc element encoding genes for chlorochatechol-degrading enzymes [17] ; (2) PAGI-1 (for P. aeruginosa genomic island 1), which may confer protection against oxidative damage [18] ; 206  PACS181  7  3  4  5  6  5  3  PACS2069  7  3  4  0  7  6  0  102  PACS458  12  3  9  11  8  2  0  PACS10223  12  3  9  3  8  2  0  4  PACS171b  14  3  11  15  8  5  0  PACS88  14  2  12  1  8  6  1  Total  66  17  49  35  45  19  4 a The number of GenVal-predicted insertions containing DNA that is absent from the reference PAO1 genome but present in sequenced P. aeruginosa strains PACS2 (GenBank Accession No. NZ_AAQW00000000) and/or PA14 (GenBank Accession No. NC_008463).
and (3) the reversibly integrating plasmid pKLC102 [19] . The 103-kb pKLC102 genomic island was present in the early isolate of Patient 4, but was conspicuously absent from the late isolate. The remaining 8 of these 17 shared insertions contained Rhs elements and DNA sequences that aligned to PAO1 open reading frames (ORFs) from disparate regions of the PAO1 genome. Rhs elements are complex sequences that include a 3.7-kb GC-rich core ORF putatively encoding a cell surface ligand-binding protein, a highly variable second ORF carrying a cytoplasmic membrane transport signal, and one or more insertion sequences [20] . Some Rhs elements, including one insertion in isolates from Patient 206, also include an upstream "vgr" component (for Val-Gly dipeptide repeat motif) that is a marker for genomic islands in P. aeruginosa [10] . Forty-nine insertions from 25 regions, 24 of which were unique relative to PAO1, were PACS-strain-specific (Table 2) . Thirty-five fosmids spanning 23 of these regions were sequenced to provide complete coverage of the insertions. Two insertion regions common to both strains from Patient 4 were not investigated (not shown), because initially they were identified as being shared with the isolates from Patient 9. Annotation of the sequenced insertions revealed ORFs encoding a range of functions, including toxin production, metabolism, secretion, and biodegradation, in addition to bacteriophages and uncharacterized ORFs. An annotation summary is reported in Table 3 . The paired early and late isolates from a given patient shared all strainspecific insertions, with the exception of a second copy of 13 ORFs from PAGI-4 [19] that was found only in the late strain from Patient 4. This insertion in the late isolate, in conjunction with the deletion of the pKLC102 genomic island (discussed above), suggests either that the early and late isolates from Patient 4 are not clonal or that the late strain lost DNA, and acquired a second copy of PAGI-4 ORFs, while residing in the host. The latter seems more likely, given support for clonality of PACS171b and PACS88 from multilocus sequence typing [6] and the extent of shared structural variation among these two isolates (Table 3) . Two copies of similar DNA sequence also were found in isolates from Patient 102, in which the same uncharacterized bacteriophage was inserted at PA2583.1 tRNA-Gly and PA2603.1 tRNA-Ser.
Coincidentally, this tRNA-Ser gene was the sole example in our study of unrelated strains sharing an insertion site. The φCTX cytotoxinconverting phage [21] was inserted into this gene in both isolates from Patient 206.
A total of 45 deletions from 12 regions were found in the paired isolates from Patients 4, 102, and 206 (Supplementary Table 2 ). In comparison to DNA microarrays, GenVal-predicted deletions were relatively broad in scope due to the software's dependence on MCDfingerprint data, and no further sequence analysis was conducted to fine-tune these regions. Despite this, all GenVal-predicted deletions in PACS171b and PACS88 from Patient 4 and PACS181 from Patient 206 overlapped with those reported by the DNA microarray analysis of Ernst et al. [10] , with one exception ( Supplementary Table 2 ); however, a minimum of 12 ORFs, including putative enzymes and hypothetical proteins, were absent in this region in 12 of the 20 strains in the Ernst et al. study, suggesting that these PAO1 ORFs are commonly absent in other Pseudomonas strains. Additional deletions identified by microarray but absent from GenVal predictions either were smaller than our 3-kb threshold or overlapped with larger insertions and were characterized as such by the software.
Six unique rearrangement breakpoints were found in the six isolates (Supplementary Table 2 ). Two of these breakpoints were also shared with Patient 9 isolates and delimit an inversion that resulted from a homologous recombination event between rrnA and rrnB previously identified as unique to the reference sequence PAO1 isolate [5] . Three other breakpoints were identified in all isolates from Patient 4 and Patient 206 and were validated by sequencing three fosmids from PACS181. One additional breakpoint, found in the late isolates from Patient 4 and Patient 206, was confirmed by sequencing a fosmid from PACS88.
Discussion
We have demonstrated the ability of LIGAN technology to characterize structural variation in four pairs of early-late isolates of P. aeruginosa from CF patients. In particular, we have used the technology to identify genomic islands that are variably present across strains and have been shown to account for 10% or more of a given genome [8] . These islands are often flanked by repeat sequences and are frequently adjacent to tRNA genes [1] . Indeed, seven of the strain-specific islands sequenced in the present study were adjacent to tRNA genes (Table 3) , as were three of the islands shared with PACS2 and/or PA14. Genomic islands can be created by integration into the host chromosome by the use of various mobile genetic elements, including plasmids, bacteriophages, and transposons. Such elements are abundant in our results (Table 3) . Known genomic islands identified in our study include the pyoluteorin biosynthetic cluster, the tellurite-resistance operon, PAGI-1, PAGI-4, and five integrated bacteriophages, φCTX, B3, F10, F116, and Pf1. Four additional bacteriophage-containing regions include genes encoding integrases, phage capsid and tail proteins, and various numbers of hypothetical proteins with similarity to previously identified bacteriophages. These findings suggest that known Pseudomonad bacteriophages may be more widespread across strains than previously recognized and that there are additional bacteriophages yet to be described that commonly infect P. aeruginosa strains. LIGAN technology overcomes the two major limitations of existing methods for detecting structural variants by readily identifying genomic regions that are not represented in the sequenced reference strain(s) and providing a genomic context for variable regions. Furthermore, results from LIGAN studies can be readily integrated with other experimental approaches to provide a more comprehensive strategy for investigating genetic variation. For example, novel DNA sequences identified using LIGAN technology can expand "universal" microarray chips, and information about the structure of a query genome can help place short DNA sequence reads from new sequencing technologies [22] , such as "sequencing by synthesis" or "sequencing by hybridization," into the context of the whole genome. These ultra-high-throughput sequencing technologies produce sequence data at a significantly increased depth of coverage and at reduced costs; however, these technologies produce short reads that are about 30-40 (Solexa and ABI SoLID technologies) or 100-200 (454 technology) bases long. These sequence data have primarily been used to tile and assemble query genomes against a known reference genome [23] . The current study has revealed that Pseudomonas genomes can be 3-9% structurally variant from a reference genome. Assembling against reference genomes will reveal most of the singlenucleotide polymorphisms and other small genetic differences, but will not be able to place reliably structurally variant regions in the context of reference genomes. For example, observed deleted sequences could be due to a lack of data acquisition from the affected regions; and novel insertions, as well as inversions and translocations, would be more difficult to detect and to place in the query genome. Furthermore, as noted by Bentley [23] with regard to de novo assembly of genomes with data generated by ultra-highthroughput sequencing technologies, "multiple new strategies will be developed for recovering specific fractions of sequence (e.g. those generated by long PCR or hybrid selection) that might be missed in a first round of [ultra-high-throughput] sequencing." LIGAN technology offers the appropriate tools to be able to identify and characterize such regions.
Structural variation in the human genome is receiving much attention, because structural variants contribute significantly to human diversity and disease susceptibility [2, 24] . As LIGAN technology was being developed, it was used partially to refine structural variation analysis of the human genome [24] [25] [26] and to define the contribution of structural variants to euchromatic gaps [27] in the finished human genome assembly [28] . In all of these studies, GenVal software was used to validate whether a fosmid clone spanning a potentially variant locus was indeed structurally variant by comparing the fosmid paired-end sequence and the MCD fingerprint data with the corresponding sequence region derived from the reference human genome assembly [24] [25] [26] [27] . LIGAN technology is thus universally applicable and highly scalable and allows genome-scale structural variation analysis of any species for greater understanding of the extent of genome diversity.
Materials and methods
Bacterial strains P. aeruginosa strains used in this study are listed in Table 1 . Clinical isolates from a given patient are considered to be clonal based on multilocus sequence typing [6] . Initial isolation and culture of PACS are described in Burns et al. [29] .
Fosmid libraries
Chromosomal DNA of each isolate was extracted from 25-ml overnight Luria broth cultures using Genomic-Tip 100/G or DNeasy protocols (Qiagen, Valencia, CA, USA). The amount of high-molecular-weight genomic DNA was assessed by pulsed-field gel electrophoresis in a DRIII CHEF gel apparatus (Bio-Rad, Hercules, CA, USA). Deep fosmid libraries were constructed in the pCC1Fos vector (Epicentre, Madison, WI, USA) according to the standard protocols described earlier [30] . Independent fosmid clones were randomly picked and arrayed into 384-well plates, each well containing 90 µl of freezing medium (10 g/L tryptone, 5 g/L yeast extract, 10 g/L NaCl, 6.3 g/L K 2 HPO 4 , 1.8 g/L KH 2 PO 4 , 0.5 g/L sodium citrate, 0.9 g/L (NH 4 ) 2 SO 4 , 4.4% glycerol) supplemented with 12 µg/ml tetracycline. Plates were incubated for 18 h at 37°C, then frozen, and stored at −80°C.
Fosmid paired-end and shotgun sequencing
Fosmid DNA was isolated in a 96-well format using the CosMCPrep kit (Agencourt Biosciences Corp., Beverly, MA, USA) and sequenced with the BigDye Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems, Foster City, CA, USA) using the forward (GTTTTCCCAGTCACGACGTT) and reverse (GCGGATAACAATTTCACACAGGAA) sequencing primers. The target mate-pair end-sequence success rate was N85% with minimal sequence quality of 100 Q20 (error probability of 1:100) bases per read.
Selected fosmid clones were subjected to shotgun sequencing, as described [31] . The shotgun sequence data were assembled and viewed using PHRED/PHRAP/CONSED software tools [32] [33] [34] . The sequence quality and contiguity of the shotgun data were improved, initially by carrying out three rounds of experiments designed by the Autofinish tool in Consed [35] , followed by directed finishing experiments designed by an expert finisher, as previously described [36] .
Fosmid DNA fingerprinting
Fosmid DNA was isolated using a standard alkaline-lysis protocol in a 96-well format. Final DNA pellets were dissolved in 40 µl 1 × TE buffer (pH 8.0) supplemented with RNase A and RNase T1 to final concentrations of 5 and 0.05 U/µl, respectively. Sixmicroliter aliquots of fosmid DNA were independently digested in 10-µl reactions with 5 units each of NcoI, SmaI, and XhoI restriction enzymes and incubated for 2 h at 37°C. Five-microliter aliquots of digested DNA samples were loaded into 0.8% agarose gels (gel dimension 19 × 19 × 0.5 cm). Each gel contained 53 lanes, including 48 lanes of digested fosmid DNA samples in four equal sets interspersed between five marker lanes (1 kb DNA Extension Ladder; Invitrogen, Carlsbad, CA, USA). Gel electrophoresis was carried out in 2× GGB buffer [11] at 8 V/cm in a custom-made chamber holding four gels with 4°C circulating buffer for 17-18 h. Gels were stained for 1 h with SYBR Green I (Invitrogen) diluted 1:20 in 2× GGB. The stained gels were scanned on a Typhoon 8600 variable mode imager (Amersham Biosciences, Piscataway, NJ, USA). The digital gel images were analyzed with Quantitative Gel Analysis Program (QGAP) software developed at UWGC (http://depts.washington.edu/uwgcmed/software.html) that provided estimates of the size and fragment multiplicity of each band. An important quality control step involved comparing the size estimates from three separate restriction digests for each fosmid. The average deviation of these size estimates was approximately 5% for all clones in this study; however, the deviation ranged up to 30%, because of spurious band calls or the presence of few, or no, sites for a particular enzyme. Gel lanes with spurious band calls were manually edited, but this practice involved b2% of the sample lanes.
Sequence annotation
Novel sequences were manually annotated as previously described [36] with the Prokaryotic Genome Annotation Tool (http://depts.washington.edu/ventures/ UW_Technology/Express_Licenses/pgat.php). ORFs of greater than 30 amino acids were predicted by GLIMMER and were subsequently checked manually. Candidate ORFs were investigated for coding sequence by comparison to the COG (http://www. ncbi.nlm.nih.gov/COG/), PFAM (http://www.sanger.ac.uk/Software/Pfam/), PROSITE (http://us.expasy.org/prosite/), and Gene Ontology (http://www.geneontology.org/) databases. Subcellular locations of putative proteins were predicted using PSORT-B (http://www.psort.org/psortb/), TMHMM (http://www.cbs.dtu.dk/services/TMHMM/), 1and SignalP (http://www.cbs.dtu.dk/services/SignalP/). BLASTX was used to compare clinical strain sequences to GenBank sequences (http://www.ncbi.nlm. nih.gov/BLAST/).
